This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Index levels are a useful barometer for market strength. This intro explains what index levels represent and how you can read them to inform your analysis.
27,688 articlesA notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
June brings a wave of AI-focused optimism to fintech stocks. Nu Holdings shines as AI-powered lending gains attention...
NuScale Power has sparked excitement around small modular reactors, but does the hype translate into real investing u...
Netflix’s strategic shift sent a ripple through the market, highlighting how breakup fees and deal terms shape stream...
Two senior researchers depart the Ethereum Foundation, intensifying leadership churn. Market watchers split on whethe...
Compass is broadening its northern Arizona footprint with a new leadership lineup in Flagstaff, aiming to capture lux...
Blue Origin is pursuing a $130 billion private-market valuation, signaling a bold push by jeff bezos’s space company ...
Bitcoin trades hold near the $67,000 level as traders weigh fresh geopolitical risks. Analysts warn that the situatio...
Toll Brothers raises its 2026 delivery guidance on persistent luxury demand and better-than-expected absorption. The ...
A AI-powered crypto project is stirring excitement. This deep dive explains how Bittensor could crack the top 10 by m...
Worldcoin schedules a 43% reduction in daily WLD unlocks ahead of July 24, but nearly half of the supply has already ...
Oil-driven volatility keeps the S&P 500 near unchanged on March 11, 2026, as traders weigh supply risks and central-b...